🌟 We believe in the power of diversity and the strength it brings to our team. This belief is rooted in one of our core values, #CelebrateEveryLight. We aim to encourage and listen to different perspectives because understanding and progress ignites when we honor each flare. #oneflare #bebrilliant #flaretx
Flare Therapeutics
Biotechnology Research
Cambridge , MA 5,161 followers
Trailblazing the path to target transcription factors and discover precision medicines for cancer & other disease areas
About us
Our team ‘brings it’ every day for one mission: to conquer transcription factors and create cutting-edge medicines for patients. Flare Therapeutics is lighting up a new therapeutic space with an entirely different approach to decipher the biology of transcription factors to develop small molecule medicines. Based on insights from the seminal work of our scientific founders, the FlareTx team is leveraging the power of ‘switch sites’ as druggable regions that hold the control for predictable and profound changes in DNA transcription, and therefore, gene expression. Our drug discovery to target ‘switch sites’ has rapidly advanced, resulting in our pipeline of drug programs that address well-validated transcription factors, initially focused on precision oncology.
- Website
-
http://www.flaretx.com
External link for Flare Therapeutics
- Industry
- Biotechnology Research
- Company size
- 11-50 employees
- Headquarters
- Cambridge , MA
- Type
- Privately Held
- Founded
- 2021
Locations
-
Primary
Cambridge , MA, US
Employees at Flare Therapeutics
Updates
-
Introducing our newest Flares! Please join us in welcoming Doug, Celine and Hannah to the Flare Therapeutics team. With Doug at the helm as our new CEO and Celine and Hannah joining the science teams, we know their collective experience will stoke the flames of our mission to conquer the biology of transcription factors and develop cutting-edge medicines for patients. Interested in joining us? Explore our current job openings: https://lnkd.in/ePNXz9sF #bringyourflare #team #oneflare #welcome
-
-
From July 1-5, the FlareTx team will be off to rest, relax and enjoy some summer fun. We believe prioritizing a healthy work-life balance fuels excellence and reignites our flames. We wish everyone a happy July 4th and look forward to connecting when we return! #SummerRecharge 🔋 #WorkLifeBalance #FlareTx #IndependenceDay
-
-
Happy Pride Month! We are proud to support and celebrate diversity in all its forms, including the spectrum of identities and experiences within our team and community. At Flare Therapeutics, we’re committed to fostering an inclusive environment where innovation thrives because every voice is heard. We #CelebrateEveryLight because we believe science relies on diverse perspectives to discover new possibilities. #Pride2024 #diversityinSTEM #flaretx #daretoflare
-
-
Our President and CFO, Daphne Karydas, will present a company overview at the upcoming Goldman Sachs 45th Annual Global Healthcare Conference on Monday, June 10th. Join her to learn more about FlareTx’s clinical progress and how the company is trailblazing a path to drugging transcription factors. #biotechnology #goldmansachs #flaretx
-
-
👟 🎗 FlareTx team members laced up their sneakers and participated in the Bladder Cancer Advocacy Network's Boston Walk to End Bladder Cancer to increase awareness and gather crucial funds for bladder cancer advocacy and research and show their support for #BladderCancerAwarenessMonth. Find out more about BCAN resources here: https://bcan.org/ #flaretx #urothelialcancer
-
-
📊 Bijal K. presented a poster on our novel Sponsored Testing Program, GPS (Genome PPARG Study), as part of our ongoing precision medicine strategy to identify genetically defined advanced UC patients for #FX909 clinical trial enrollment at the American Association for Cancer Research’s Bladder Cancer: Transforming the Field Conference in Charlotte, North Carolina. Learn more about FX-909 here: https://lnkd.in/eN8A6G4q #flaretx #urothelialcancer
-
-
We’re excited and honored that Citeline has named Flare Therapeutics as the winner of the Most Successful Early Phase Research (Preclinical & Phase I) award at this year’s #CitelineAwards! FlareTx is committed to advancing innovative research targeting transcription factors to discover precision medicines for cancer and other diseases, with the goal of offering meaningful treatment solutions for patients. We thank the Citeline Awards committee for this prestigious award and offer our congratulations to all category finalists. Learn more about FlareTx’s pipeline, including our lead candidate FX-909, here: https://lnkd.in/eyjjGmUN #biotechnology #flaretx #daretoflare
-
-
May is Bladder Cancer Awareness Month, a time to raise awareness about a disease that impacts over 1.9m patients globally, with 610,000 people newly diagnosed each year. The team at FlareTx stands with patients, caregivers and physicians as we seek to innovate and advance our research, which we hope will one day offer better solutions for patients. This month we aim to better understand the needs and experiences of those who are affected by this disease. We will raise awareness through our participation in two events, Bladder Cancer Advocacy Network’s 2024 Walk to End Bladder Cancer and Bladder Cancer Canada’s Canada Walks for Bladder Cancer. #BladderCancerAwarenessMonth #LiftTheTorch #transcriptionfactors #biotech
-
-
The Flare Therapeutics team gathered for a group pottery-making class where we had the opportunity to showcase our creativity and get to know our new CEO. https://lnkd.in/eXgfhqhh Our team is made up of passionate individuals brought together by shared values and a commitment to our mission. One of our core values, #TendTheFire, grounds us in the idea that with the right mix of chemistry and care, the smallest of sparks can become a roaring blaze, just like the finished pottery pieces. 🔥 At FlareTx, we #DaretoFlare. #oneflare #bebrilliant #flaretx